Integrated Cannabis Solutions, Inc. (IGPK)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Integrated Cannabis Solutions, Inc. (IGPK) trades at $0.00 with AI Score 60/100 (Grade B+). Integrated Cannabis Solutions, Inc. focuses on the cultivation and processing of hemp and biomass in the United States. Market cap: $841,660, Sector: Healthcare.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for IGPK: IGPK does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates IGPK against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
IGPK: 3/4 perspectives are bullish. Dominant signal: Seth Klarman bullish.
How is this calculated? →Integrated Cannabis Solutions, Inc. (IGPK) Healthcare & Pipeline Overview
Integrated Cannabis Solutions, Inc. specializes in the cultivation and processing of hemp and biomass across the United States. The company aims to supply Cannabidiol (CBD) or isolate to manufacturers and pharmaceutical firms for diverse CBD-infused products, including edibles, vitamins, and topicals, while also developing farmer co-ops for supply chain stability.
What Is the Investment Thesis for IGPK?
Integrated Cannabis Solutions, Inc. (IGPK) presents a unique profile within the evolving US hemp and CBD processing sector, characterized by its B2B supply model. The company's strategic intent to cultivate and process hemp/biomass for sale as CBD or isolate to manufacturers and pharmaceutical companies positions it to capitalize on the increasing demand for cannabinoid-infused products. Key value drivers include its planned establishment of farmer co-ops and long-term purchase contracts, which are critical for ensuring a stable and cost-effective supply chain in a nascent industry. With a P/E ratio of 9.0, a modest profit margin of 0.5%, and a gross margin of 2.4%, IGPK operates with tight financial metrics, indicative of its early-stage development and the competitive landscape. Growth catalysts for IGPK are primarily tied to the expansion of the broader CBD market and its ability to secure significant supply agreements with product manufacturers. The company's focus on diverse end-products, from edibles and vitamins to topicals and vaping liquids, provides multiple avenues for revenue generation. However, as an OTC-listed entity with a 842K market capitalization and only one employee, IGPK faces significant operational and financial risks, including the inherent volatility and regulatory uncertainty of the cannabis industry. Its ability to secure necessary funding and successfully scale its operations will be paramount to realizing its growth potential, requiring close monitoring of execution and market developments.
Based on FMP financials and quantitative analysis
IGPK Key Highlights
- Market Capitalization of 842K, reflecting its micro-cap status within the market.
- Price-to-Earnings (P/E) ratio of 10.31, indicating its valuation relative to earnings.
- Profit Margin of 0.5%, suggesting a very lean operational profitability.
- Gross Margin of 2.4%, highlighting the cost structure of its processing activities.
- Operates with 1 employee, underscoring its highly streamlined or nascent operational scale.
Who Are IGPK's Competitors?
IGPK is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
| EGRX Eagle Pharmaceuticals, Inc. | $0.67 | +0.00% | $8.82M | 60 |
| ADMP Adamis Pharmaceuticals Corporation | $0.78 | +0.85% | $7.25M | 61 |
| ALIM Alimera Sciences, Inc. | $5.54 | -0.18% | $301.29M | 60 |
| NPNKF Nippon Shinyaku Co., Ltd. | $32.75 | +4.30% | $2.21B | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are IGPK's Key Strengths?
- Focused B2B model in hemp/biomass processing, serving diverse CBD product manufacturers.
- Strategic plan to establish farmer co-ops and long-term contracts for supply chain stability.
- Potential for first-mover advantage in specific regional markets within the US hemp industry.
- Engagement in a growing market for CBD and cannabinoid-derived products.
What Are IGPK's Weaknesses?
- Extremely small operational scale with only one employee and a 842K market capitalization.
- Very low profitability with a 0.5% profit margin and 2.4% gross margin.
- Trades on the OTC Other tier, implying limited transparency and disclosure.
- Negative Beta (-0.03) suggests unpredictable correlation with broader market movements.
What Could Drive IGPK Stock Higher?
- Successful establishment of a co-op with local farmers to ensure a consistent biomass supply.
- Entry into long-term purchase contracts for hemp biomass, stabilizing raw material costs and availability.
- Securing significant supply agreements with manufacturers or pharmaceutical companies for CBD/isolate sales.
- Continued development and scaling of hemp growing and processing operations within the United States.
What Are the Key Risks for IGPK?
- Significant regulatory uncertainty and evolving legal frameworks within the broader cannabis industry.
- Inherent volatility and speculative nature of the cannabis market, impacting demand and pricing.
- Challenges in securing adequate funding and capital for operational expansion and scaling efforts.
- Limited public disclosure and transparency due to its OTC Other tier listing, hindering investor confidence.
- Intense competition from more established or better-funded players in the hemp cultivation and CBD processing sector.
What Are the Growth Opportunities for IGPK?
- Expansion into diverse CBD product categories: Integrated Cannabis Solutions, Inc. is strategically positioned to capitalize on the burgeoning demand for CBD across multiple consumer product segments. By supplying processed CBD or isolate to manufacturers, the company enables the creation of edibles for human consumption, a variety of vitamins and multi-vitamins, and a comprehensive range of topical products including oils, tinctures, creams, and salves, alongside vaping liquids. The global CBD market is projected to continue its robust growth, with significant expansion anticipated in wellness and consumer goods. IGPK's B2B model allows it to indirectly benefit from this diversification without the complexities of direct consumer marketing, providing a broad addressable market for its processed materials over the next 3-5 years.
- Strategic co-op development and supply chain stabilization: A key growth driver for IGPK involves its proactive plan to promote and assist in the establishment of a co-operative with local farmers. This initiative is designed to secure a consistent and reliable supply of hemp biomass, which is fundamental to its processing operations. By fostering these partnerships and entering into long-term purchase contracts, IGPK aims to mitigate supply chain risks, ensure raw material quality, and potentially achieve cost efficiencies. A stable and predictable supply chain is a significant competitive advantage in the often-volatile agricultural commodity markets, enabling more consistent production and delivery schedules for its B2B clients over the medium to long term (3-7 years).
- B2B supply to pharmaceutical companies: The company's explicit intention to sell processed CBD or isolate to pharmaceutical companies represents a substantial growth opportunity. As scientific research continues to validate the therapeutic potential of cannabinoids, the demand for pharmaceutical-grade CBD is expected to rise significantly. Supplying to this highly regulated sector requires stringent quality control and consistency, which, if achieved, could command premium pricing and establish IGPK as a reliable partner in the medical cannabis supply chain. This segment offers a pathway to higher-value markets and could provide substantial revenue growth as regulatory frameworks for cannabinoid-based medicines evolve over the next 5-10 years.
- Geographic expansion within the US hemp market: Integrated Cannabis Solutions, Inc. currently focuses on growing and processing hemp or biomass in the United States. As federal and state regulations surrounding hemp cultivation and CBD production continue to evolve and potentially liberalize, there will be opportunities for IGPK to expand its operational footprint. This could involve establishing new cultivation sites or processing facilities in different regions of the US to tap into local farmer networks and serve new manufacturing hubs. Such expansion would allow the company to increase its overall biomass processing capacity and reach a broader customer base, leveraging regional market demands and logistical efficiencies over a 2-5 year timeline.
- Product diversification into higher-purity isolates: While the company aims to sell processed CBD or isolate, there is an inherent opportunity to refine its processing capabilities to produce higher-purity CBD isolates or other specific cannabinoid isolates. Higher-purity products typically command premium prices and cater to specialized applications, particularly in the pharmaceutical and high-end cosmetic industries where precise dosing and formulation are critical. Investing in advanced extraction and purification technologies could differentiate IGPK from competitors and open doors to more lucrative market segments. This strategic enhancement of product offerings could significantly boost profit margins and market positioning within a 3-6 year timeframe.
What Opportunities Does IGPK Have?
- Expansion into higher-value pharmaceutical applications for CBD and isolates.
- Capitalizing on the increasing consumer demand for diverse CBD-infused products (edibles, topicals, vitamins).
- Geographic expansion within the US as regulatory clarity for hemp and CBD evolves.
- Enhancing processing capabilities to produce higher-purity isolates for premium markets.
What Threats Does IGPK Face?
- Ongoing regulatory uncertainty and evolving legal frameworks in the cannabis industry.
- Intense competition from established and emerging players in the hemp cultivation and processing sector.
- Significant challenges in securing adequate funding and scaling operations due to small size and OTC listing.
- Market volatility and potential for price fluctuations in biomass and CBD products.
What Are IGPK's Competitive Advantages?
- Potential for first-mover advantage in specific regional US hemp processing markets.
- Planned establishment of farmer co-operatives to secure a stable and cost-effective biomass supply.
- Focus on B2B supply chain integration, serving as a foundational input provider.
- Development of long-term purchase contracts for raw materials, enhancing supply predictability.
What Does IGPK Do?
Integrated Cannabis Solutions, Inc. (IGPK), headquartered in Coconut Creek, Florida, traces its origins back to 2003 when it was initially established as Integrated Parking Solutions, Inc. The company underwent a significant strategic pivot in April 2014, formally changing its name to Integrated Cannabis Solutions, Inc. to reflect its new focus on the burgeoning cannabis sector. Currently, IGPK is primarily engaged in the growing and processing of hemp or biomass within the United States. The company's business model is centered on a B2B approach, where it intends to sell its processed material, specifically in the form of Cannabidiol (CBD) or isolate, to a diverse clientele of manufacturers and pharmaceutical companies. These clients, in turn, utilize IGPK's raw materials for the manufacture, distribution, and sale of a wide array of CBD-related products. This includes consumer goods such as edibles designed for human consumption, various vitamin and multi-vitamin supplements, and a comprehensive range of topical products for human use. The topical product line encompasses oils, tinctures, creams, salves, and vaping liquids, demonstrating the broad applicability of IGPK's processed materials across different market segments. Beyond its direct processing and sales activities, Integrated Cannabis Solutions, Inc. is also strategically planning to foster and support the establishment of a co-operative model with local farmers. This initiative is designed to achieve a consistent and reliable supply of biomass, a critical input for its processing operations. By engaging in such co-ops and entering into long-term purchase contracts, the company aims to secure its supply chain, mitigate raw material price volatility, and build sustainable relationships within the agricultural community. This integrated approach, from cultivation support to processing and B2B supply, underscores IGPK's ambition to be a foundational component in the US CBD product manufacturing ecosystem.
What Products and Services Does IGPK Offer?
- Engages in the growing of hemp or biomass in the United States.
- Conducts processing of hemp or biomass to extract Cannabidiol (CBD) or isolate.
- Intends to sell processed CBD or isolate to manufacturers for product formulation.
- Aims to supply pharmaceutical companies with CBD or isolate for medicinal applications.
- Supports the production of CBD edibles, vitamins, multi-vitamins, and topical products.
- Facilitates the creation of topical CBD products including oils, tinctures, creams, and salves.
- Plans to promote and assist in establishing co-ops with local farmers for biomass supply.
- Seeks to enter into long-term purchase contracts for consistent biomass acquisition.
How Does IGPK Make Money?
- B2B sales of processed hemp derivatives (CBD, isolate) to other companies.
- Revenue generation from bulk sales of processed Cannabidiol to manufacturers.
- Potential income from long-term supply agreements for biomass and processed materials.
- Leveraging a co-op model with farmers to secure raw material supply and manage costs.
What Industry Does IGPK Operate In?
Integrated Cannabis Solutions, Inc. (IGPK) operates within the Drug Manufacturers - Specialty & Generic industry, specifically carving a niche in the upstream segment of the US hemp and Cannabidiol (CBD) market. This sector is characterized by its rapid evolution, driven by shifting consumer preferences and an increasingly complex regulatory landscape. The broader cannabis industry, which encompasses cultivation, processing, distribution, and retail, is marked by significant volatility and intense competition. IGPK positions itself as a crucial B2B supplier, focusing on the growing and processing of hemp biomass to produce CBD or isolate. This strategy aims to serve manufacturers and pharmaceutical companies, distinguishing it from direct-to-consumer brands. Market trends indicate a growing demand for CBD-infused products across various categories, including health and wellness, food and beverages, and pharmaceuticals. However, the competitive landscape includes numerous established and emerging players, from large agricultural operations to specialized extraction facilities, all vying for market share. IGPK's success hinges on its ability to secure consistent biomass supply through farmer co-ops and establish reliable long-term purchase contracts, thereby solidifying its position as a trusted raw material provider in this dynamic industry.
Who Are IGPK's Key Customers?
- Manufacturers of various CBD-related consumer products.
- Pharmaceutical companies developing cannabinoid-based medications.
- Companies producing edibles infused with CBD.
- Firms specializing in CBD-infused vitamins and multi-vitamins.
- Producers of topical CBD products such as oils, creams, and vaping liquids.
F-Score 4/9Financial Health
Integrated Cannabis Solutions, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 41.02 places it in the safe zone, indicating low near-term bankruptcy risk.
IGPK Valuation & Market Position
With a 842K market cap, Integrated Cannabis Solutions, Inc. sits in the micro-cap segment of the market. Relative to its peer group, IGPK's quantitative score of 60/100 is roughly in line with the peer average of 66/100.
ROE 6%Key Financial Metrics
Return on equity for Integrated Cannabis Solutions, Inc. stands at 5.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 5.8%, showing how much profit it generates from its asset base. IGPK trades at a trailing price-to-earnings ratio of 8.97, below the Healthcare sector average of ~23x. Its free cash flow yield is 58.4%, a gauge of the cash the business throws off relative to its market value. Its earnings yield is 14.9%, the inverse of the P/E and a quick read on earnings relative to price.
Company Profile
Integrated Cannabis Solutions, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Coconut Creek, US. The company is led by CEO Eugene L. Caiazzo. IGPK has traded publicly since 1997.
IGPK Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2024
Bull Case vs Bear Case
Bull Case
- Focused B2B model in hemp/biomass processing, serving diverse CBD product manufacturers.
- Strategic plan to establish farmer co-ops and long-term contracts for supply chain stability.
- Potential for first-mover advantage in specific regional markets within the US hemp industry.
- Engagement in a growing market for CBD and cannabinoid-derived products.
Bear Case
- Extremely small operational scale with only one employee and a 842K market capitalization.
- Very low profitability with a 0.5% profit margin and 2.4% gross margin.
- Trades on the OTC Other tier, implying limited transparency and disclosure.
- Negative Beta (-0.03) suggests unpredictable correlation with broader market movements.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
IGPK Latest News
No recent news available for IGPK.
IGPK Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for IGPK.
Price Targets
Wall Street price target analysis for IGPK.
IGPK MoonshotScore
What does this score mean?
The MoonshotScore rates IGPK's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Eugene L. Caiazzo
Chief Executive Officer
Eugene L. Caiazzo serves as the Chief Executive Officer of Integrated Cannabis Solutions, Inc., overseeing the company's strategic direction and day-to-day operations. While specific details regarding his educational background and extensive career history prior to his current role are not publicly available, Mr. Caiazzo is responsible for managing the company's single employee and guiding its focus on hemp cultivation and biomass processing. His leadership is central to the company's efforts to establish its presence in the US CBD supply chain, including the development of farmer co-operatives and securing long-term purchase contracts.
Track Record: Under Eugene L. Caiazzo's leadership, Integrated Cannabis Solutions, Inc. has maintained its strategic focus on the B2B supply of processed hemp and CBD isolate to manufacturers and pharmaceutical companies. Key initiatives include the planning and promotion of a co-op model with local farmers to ensure a consistent biomass supply and the intention to enter into long-term purchase contracts. His tenure has seen the company navigate the evolving landscape of the cannabis sector, aiming to establish foundational supply chain relationships.
IGPK OTC Market Information
Integrated Cannabis Solutions, Inc. (IGPK) trades on the OTC Other tier, which is the lowest and most speculative tier of the OTC Markets Group. Unlike major exchanges such as the NYSE or NASDAQ, which have stringent listing requirements regarding financial reporting, minimum share prices, and corporate governance, the OTC Other tier has minimal to no financial disclosure requirements. Companies in this tier are often characterized by limited public information, making comprehensive due diligence challenging for investors. This tier is typically reserved for companies that do not meet the standards for OTCQX, OTCQB, or even Pink Open Market, signifying a higher level of risk and a lack of transparency compared to regulated exchanges.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited public disclosure and transparency, making it difficult to assess financial health and operations.
- Extremely low trading volume and liquidity, leading to wide bid-ask spreads and difficulty in executing trades.
- Increased susceptibility to market manipulation due to minimal oversight and thin trading.
- Challenges in raising capital and attracting institutional investors due to its OTC Other listing status.
- Lack of consistent financial reporting makes fundamental analysis highly speculative.
- Verify the company's current business operations and actual progress in hemp cultivation and processing.
- Research the background and track record of management, particularly Eugene L. Caiazzo, beyond publicly available summaries.
- Seek out any available financial statements or disclosures, however limited, to understand revenue and cost structures.
- Assess the regulatory compliance status of its hemp and CBD operations in relevant US states.
- Evaluate the market demand for its specific CBD/isolate products and potential for securing B2B contracts.
- Investigate any legal or regulatory actions against the company or its management.
- Understand the company's capital structure and any outstanding debt or dilution risks.
- Clearly stated business focus on hemp growing and processing for B2B supply.
- Founded in 2003 (albeit under a different name), indicating a history as a corporate entity.
- Headquartered in Coconut Creek, Florida, providing a physical base of operations.
- Specific intentions to establish farmer co-ops and long-term purchase contracts, suggesting a structured business plan.
- Explicitly targets manufacturers and pharmaceutical companies, outlining a defined market strategy.
What Investors Ask About Integrated Cannabis Solutions, Inc. (IGPK) — Healthcare
What is Integrated Cannabis Solutions, Inc.'s primary business model and target market?
Integrated Cannabis Solutions, Inc. (IGPK) operates with a clear business-to-business (B2B) model, focusing on the upstream segment of the US hemp and CBD market. Its primary activity involves the growing and processing of hemp or biomass to produce Cannabidiol (CBD) or isolate. The company's target market comprises manufacturers and pharmaceutical companies that require these processed materials as raw ingredients for their own product lines. These end-products span a wide range, including edibles for human consumption, various vitamin and multi-vitamin supplements, and topical applications such as oils, tinctures, creams, salves, and vaping liquids. IGPK aims to be a foundational supplier in this expanding ecosystem.
What are the key operational challenges and opportunities for IGPK given its OTC listing and sector?
As an OTC-listed company in the cannabis sector, Integrated Cannabis Solutions, Inc. faces several operational challenges. These include navigating the inherent volatility and significant regulatory uncertainty surrounding cannabis and hemp products, which can impact market demand and operational legality. Furthermore, its OTC Other tier listing implies limited public disclosure, potentially hindering its ability to attract institutional funding or establish credibility. Opportunities, however, stem from the rapidly growing global CBD market, allowing IGPK to leverage its B2B supply model. Its strategic plan to establish farmer co-ops and secure long-term purchase contracts could stabilize its raw material supply, offering a competitive advantage in a fragmented industry.
How does Integrated Cannabis Solutions, Inc. plan to ensure a consistent supply of raw materials?
Integrated Cannabis Solutions, Inc. is actively planning to ensure a consistent and reliable supply of raw materials, specifically hemp or biomass, through a two-pronged strategy. Firstly, the company intends to promote and assist in the establishment of a co-operative model with local farmers. This collaborative approach aims to foster strong relationships with cultivators, ensuring a dedicated and predictable source of biomass. Secondly, IGPK plans to enter into long-term purchase contracts with these farmers. These contracts are designed to lock in supply volumes and potentially stabilize pricing, thereby mitigating the risks associated with raw material availability and price fluctuations in the agricultural commodity market.
What are the financial characteristics of Integrated Cannabis Solutions, Inc.?
Integrated Cannabis Solutions, Inc. (IGPK) exhibits financial characteristics indicative of a small, early-stage company operating in a niche market. As of the latest available data, the company has a market capitalization of 842K, reflecting its minimal valuation. Its P/E ratio stands at 9.0, while its profitability metrics include a profit margin of 0.5% and a gross margin of 2.4%. These margins suggest a business operating with relatively tight profitability. The company reports having only one employee, underscoring its lean operational structure. Furthermore, its Beta is -0.03, indicating a very low or inverse correlation with the broader market, which can be characteristic of highly specialized or thinly traded securities.
What are the key factors to evaluate for IGPK?
Integrated Cannabis Solutions, Inc. (IGPK) holds an AI score of 60/100 (moderate). P/E: 9.0x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does IGPK data refresh on this page?
IGPK prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven IGPK's recent stock price performance?
Integrated Cannabis Solutions, Inc. (IGPK) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Focused B2B model in hemp/biomass processing, serving diverse CBD product manufacturers. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider IGPK overvalued or undervalued right now?
Integrated Cannabis Solutions, Inc. (IGPK) trades at 9.0x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited public financial data available for a comprehensive analysis.
- OTC listing implies reduced transparency and liquidity, impacting the depth of financial assessment.